This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
If theres one thing clinicalresearchers can count on when it comes to regulations and guidance from governing bodies, its change. Its a unique opportunity to not only stay up to date with research initiatives, but also to engage with healthcare research professionals from around the country. This is a sponsored message.
says David Vulcano, LCSW, MBA, CIP, RAC, FACRP , Vice President, ClinicalResearchCompliance and Integrity, at HCA Healthcare and author of a recent ACRP White Paper on Responsible Oversight of Artificial Intelligence for ClinicalResearch Professionals. in April.
Change management is an overarching theme in innovation, with a need to mitigate and resolve barriers to change due to low institutional and personal risk tolerance, says David Burrow, PharmD, JD, Director, Office of Scientific Investigations, Office of Compliance, at the FDA Center for Drug Evaluation and Research (CDER).
Selecting the right CRO to partner with on your development program is a pivotal decision that can shape the trajectory of your product’s development. Our consultative approach ensures success by integrating research methodology, regulatory affairs strategy, and clinical operations. You have the oversight you need.
For clinicalresearch professionals, this journey often involves reconciling differing feedback from regulatory agencies, each with unique standards, priorities, and expectations. Your CRO can also play a crucial role in helping you to understand existing precedents and how they apply to your study and overall development journey.
Following the success of Issue 3 , which focused on the critical importance of patient diversity in clinicalresearch, Xtalks is thrilled to announce Xtalks Clinical Edge Issue 4. These prominent leaders will share their experiences, strategies and visions about whats next for clinicalresearch.
Institutional review boards (IRBs) play a crucial role in the ever-evolving field of clinicalresearch. Innovations in fields such as immunotherapy, cancer and chronic diseases owe their existence to clinical trials, which judiciously test and evaluate safety and efficacy.
In the rapidly evolving landscape of clinicalresearch, data has become one of the most valuable assets. Clinical Trial Management Systems (CTMS) play a pivotal role in managing this data, encompassing everything from patient information and trial protocols to sensitive medical records and regulatory documents.
Clinical trial billing compliance—ensuring that charges for therapies and other study-related elements are sent to the appropriate party—is a key concern for academic medical centers and other research organizations. Do you lose revenue in research? Are you calculating fair market value correctly?
This landmark legislation aims to create a comprehensive framework for AI development and deployment, ensuring ethical use, safety, and transparency for European Union (EU) residents. This article explores the likely impact of the AI Act on software and systems used in clinicalresearch and how it affects entities outside the EU.
Also sharing advice on breaking free of unproductive habits on Saturday was Suzanne Kincaid, CCRA, ACRP-PM, FACRP, Consultant and Owner of Responsibility Research, in her session on “The Intersection of Technology and People: Harnessing Technology to Increase Efficiency and Build Relationships.” On Day Two of ACRP 2024 in Anaheim, Calif.,
ACRP reached out to experts from graduate programs in clinicalresearch for a snapshot of how education in this field, especially at the master’s degree level, is holding up amidst rapidly evolving changes in the research enterprise itself. This diversity suggests varying levels of prior research experience and knowledge.
Many clinicalresearch professionals “fell into” this career pathway rather than choosing it deliberately from the outset. Multiple career trajectories can bring individuals into clinicalresearch,” said Kristen Gurnea, MPH, CCRC, ACRP-PM, Manager of ClinicalResearch at Renown Health.
Almost everyone I’ve met in clinicalresearch has accidentally discovered this hidden profession. Your interest in science and medicine somehow got you involved in clinicalresearch and clinical trial management. But didn’t you wish you had a crystal clear understanding of “Who’s Who In ClinicalResearch?”.
The biopharmaceutical industry has witnessed a significant surge in the number of therapeutic molecules in development, leading to a corresponding increase in the number of contract development and manufacturing organizations (CDMOs).
In the turbulent waters of the clinicalresearch workforce, with high turnover and burnout circling like relentless sharks, several leading organizations have found ways to navigate their way through and around the worst of the storm. “It We want to show them the options” that exist in the clinical trial industry, he adds.
Notably, the FDA can now mandate that confirmatory trials begin before approval, ensuring proactive validation of clinical benefits. The draft also formalizes withdrawal procedures for non-compliance, including delayed studies or failure to confirm benefits.
Strengthened regulatory compliance: Different countries have varying regulatory requirements and expectations. This compliance is crucial for the successful regulatory approval and dissemination of trial results. A globally diverse DMC ensures the trial adheres to local regulations while maintaining high ethical standards.
21 CFR Part 11 is a crucial component of regulatory compliance in clinical trials and, more broadly, any industry subject to the regulations of the U.S. This blog post will serve as a comprehensive guide to understanding and implementing 21 CFR Part 11 compliance in your clinical trials. Let’s explore.
He is currently the Principal Attorney of Kulkarni Law Firm where he focuses his practice on providing healthcare companies with legal, compliance, and regulatory advice. He has led rare disease pharmaceutical companies in developing global programs to foster clinical trial transparency and enhance public health.
The clinicalresearch industry plays a vital role in advancing medical knowledge and improving healthcare; however, the increasing complexity of clinical trials has created a perfect storm of challenges for clinicalresearch sites, posing significant risks to the efficiency, effectiveness, and sustainability of clinical trials at large.
Within the clinicalresearch enterprise, as can be seen elsewhere in business and regulatory landscapes, the terms “quality” and “compliance” often intersect, creating what some feel is a symbiotic relationship crucial for organizational success.
Sponsors must navigate varying approval processes, compliance standards and reporting requirements to ensure that trials meet both local and international guidelines. As Thomas says, The accessibility of clinical trials and clinicalresearch is what drives a significant amount of that cross-country movement.
But today, with a rise in molecularly targeted therapies, oncology development has shifted to identifying an optimal biologic dose that balances toxicity with efficacy. Project Optimus is intended to reform the dose optimization and dose selection paradigm in oncology drug development,” says Dr. Confeld.
MDS are a group of blood disorders caused by abnormal development of blood cells in the bone marrow. This progression occurs when the abnormal cells in the bone marrow increase uncontrollably, leading to the development of a more aggressive form of blood cancer. “We
In the dynamic landscape of clinical trials, ensuring compliance and maintaining high-quality standards are paramount. The field of quality and compliance in clinical trials is undergoing significant transformations driven by technological advancements, regulatory changes and evolving industry practices.
Department of Justice (DOJ) officials have made it clear in the last few years that investigation and enforcement of clinicalresearch misconduct is an increasing priority. Mingqing Xiao ) Clearly, there are a multitude of regulations that impact clinicalresearch, and it’s vital to stay up to date on the latest industry developments.
In the clinicalresearch space, GxP is a set of quality regulations and guidelines designed to establish the safety, efficacy, and integrity of pharmaceuticals, medical devices, and clinical trials. This blog explores key concepts, regulations, and the importance of GxP in delivering successful clinical trials.
As with other targeted therapies, radiopharmaceutical development requires unique and specialized strategies to ensure successful execution. Targeted Outreac h: Developing relationships with KOLs specializing in your indication can create a referral pipeline for suitable trial participants.
This Act is poised to significantly change the clinical trials landscape within the life sciences sector. As AI increasingly becomes a cornerstone in clinicalresearch and drug development, it is crucial for industry stakeholders to grasp the extensive implications of this regulation.
This achievement solidifies Cloudbyzs position as a trusted partner in advancing clinicalresearch through cutting-edge, cloud-based technologies. Cloudbyzs dual recognition underscores its commitment to innovation , regulatory compliance, and enhanced trial efficiency.
This prestigious acknowledgment places Cloudbyz among the top-performing companies globally, known for delivering scalable and intuitive CTMS solutions that empower clinicalresearch teams. Global Regulatory Compliance: Ensures compliance with 21 CFR Part 11 and other global regulations, reducing compliance risks.
In the realm of clinical trials, regulatory compliance is a cornerstone that ensures the integrity, reliability, and safety of collected data. Electronic Data Capture (EDC) systems have become integral to modern clinicalresearch, offering streamlined data management and enhanced accuracy.
VirTrial developed the program, using BlueCloud standards, while BlueCloud will provide its global networking infrastructure to Deliver, Distribute, Implement and Track (DDIT ) training competencies and certifications for business and compliance purposes. About VirTrial.
Understanding and managing post-surgical pain is pivotal in clinicalresearch for improving patient outcomes and care strategies. Compliance Issues: Ensuring consistent patient participation in reporting pain levels post-surgery can be challenging.
The regulatory issues of how to engage with patient organisations and involve patients in clinical trial design are covered by publications such as the ABPI’s Code of Practice. Improving the design of commercial research by listening to the patient voice. Improving the design of commercial research by listening to the patient voice.
As clinical trials become more complex, the need for user-centric design has never been more critical. His commitment to enhancing user experience is transforming how clinical trials are conducted, ensuring that both patients and site staff are supported throughout the process.
The clinicalresearch industry is increasingly recognizing the need for diversity, especially as it relates to the Latino population and other minorities. One major development is the expansion of clinical trials into Latin America. The latest U.S. This rapid expansion is vital when considering healthcare equity.
Especially as we exited the blockbuster drug period of psychiatric development and trials were failing with huge placebo effects, I think we started realizing that the patients going into trials were not the real-world patients that were getting treated with drugs in the clinic.
In the intricate dance of drug discovery and development, two protagonists emerge as the cornerstones of modern medicine: biologics and small molecules. Development and Approval : Small Molecules: The pathway for development and regulatory approval is well-established, with clear guidelines for demonstrating safety and efficacy.
The clinicalresearch landscape is rapidly evolving. As it becomes more complex with growing volumes of data, evolving regulations, and the pressure for faster drug development, traditional methods of clinicalresearch management are no longer sufficient. This is where the platform approach comes into play.
Maria Hopfgarten Head of Global Medical Writing PPD ClinicalResearch Business of Thermo Fisher Scientific Artificial intelligence (AI) is revolutionizing industries worldwide, and medical writing is no exception. Writers act as the ultimate quality controllers to verify the clinical relevance and regulatory compliance of AI outputs.
Achieving diversity, equity, and inclusion (DEI) in clinical trials is crucial for producing comprehensive and effective medical research benefitting all communities. DEI ensures clinicalresearch encompasses diverse populations, considering variations in gender, race, ethnicity, socioeconomic status, and more.
The field of oncology has seen significant progress in recent years, with the development of novel therapies and advancements in clinicalresearch. Targeted Therapies and Immunotherapies One of the most notable trends in cancer drug research is the development of targeted therapies and immunotherapies.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content